Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Wockhardt's Insulin Lispro vs Humalog in Type 1 Diabetes
NCT01398670Phase 3Withdrawn
- Sponsor
- Wockhardt
- Start
- Feb 2012
- Primary completion
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of insulin lispro in type 1 diabetes mellitus (T1D), sponsored by Wockhardt. Planned start Feb 2012; status: withdrawn.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01398670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01398670.